drugset
drugset / Trial / NCT00374647

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

NCT00374647 ↗

Phase 4 Completed 17 enrolled University of Cincinnati
RandomizedSingle-groupOpen-labelTreatment

Summary

Evaluate the safety and efficacy of early corticosteroid withdrawal and simultaneous calcineurin inhibitor withdrawal in recipients of primary renal allografts maintained long-term on MMF and sirolimus.

Timeline

Start
2005-03
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Background Mycophenolate Mofetil Small molecule — —
Background Sirolimus Small molecule — —

Indications

No indication recorded.